In Adenoviral Conjunctivitis, what treatment is used when presenting within the first 3 days?

Prepare for the NBEO Part III Test with detailed quizzes on patient encounters and performance skills. Access flashcards and questions with explanations to enhance your study strategy. Perfect your skills for exam success!

Multiple Choice

In Adenoviral Conjunctivitis, what treatment is used when presenting within the first 3 days?

Explanation:
Early management of adenoviral conjunctivitis aims to reduce the viral load and control inflammation to shorten illness and limit contagiousness. Using a 5% povidone-iodine wash within the first 3 days decreases viral particles on the ocular surface, which helps reduce spread and duration. Pairing this antiseptic approach with Loteprednol 0.5% four times daily provides anti-inflammatory relief with a steroid that has a relatively safer short-term profile. Adding preservative-free artificial tears and cool compresses further improves comfort and tear stability. This combination targets both the infectious agent and the inflammatory response, whereas antibiotics won’t treat a viral infection, steroids alone risk prolonging viral shedding, and observation misses an opportunity to lessen symptoms and transmission.

Early management of adenoviral conjunctivitis aims to reduce the viral load and control inflammation to shorten illness and limit contagiousness. Using a 5% povidone-iodine wash within the first 3 days decreases viral particles on the ocular surface, which helps reduce spread and duration. Pairing this antiseptic approach with Loteprednol 0.5% four times daily provides anti-inflammatory relief with a steroid that has a relatively safer short-term profile. Adding preservative-free artificial tears and cool compresses further improves comfort and tear stability. This combination targets both the infectious agent and the inflammatory response, whereas antibiotics won’t treat a viral infection, steroids alone risk prolonging viral shedding, and observation misses an opportunity to lessen symptoms and transmission.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy